Andere Sprachen Insulet Corporation

Aktien

A0MQX8

US45784P1012

PODD

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 19.04.2024			% 5 Tage	% 1. Jan.
166.2 ^USD	+0.92%		-5.12%	-23.38%

20.03.	US-Aktienmärkte schließen am Mittwoch höher, da die Fed die Zinsen stabil hält	MT
20.03.	Insulet ernennt Ana Maria Chadwick zur Finanzchefin	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024	03.04.
US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	20.03.
Insulet Names Ana Maria Chadwick Finance Chief	20.03.
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer	20.03.
Insulet Corporation Appoints Ana Maria Chadwick as Executive Vice President, and Treasurer, Effective April 22, 2024	20.03.
Insulet Corporation Announces Chief Financial Officer Changes	20.03.
3M Board Approves Healthcare Unit Spinoff -- Update	08.03.
Insulet Says Trial Shows Omnipod 5 Insulin Delivery System Superior to Pump Therapy	08.03.
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy	08.03.
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)	08.03.
Insulet to Present Results from First Omnipod 5 Randomized Controlled Trial at the 17th International Conference on Advanced Technologies and Treatments for Diabetes	06.03.
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	05.03.
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes	05.03.
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership	26.02.
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024	23.02.
Insulet forecasts weak annual revenue growth; shares drop	22.02.
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set	22.02.
Insulet: Q4 Earnings Snapshot	22.02.
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)	22.02.
Earnings Flash (PODD) INSULET CORPORATION Posts Q4 EPS $1.40, vs. Street Est of $0.66	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Insulet Corporation

Aktien

A0MQX8

US45784P1012

PODD

Andere Sprachen

Filter